Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease

Background: Recent studies have suggested soluble tumor necrotizing factor-like weak inducer of apoptosis (sTWEAK) and sCD163 may be a potential cardiovascular biomarker. We aimed to evaluate sTWEAK and sCD163 levels and predictive values in patients with chronic coronary artery disease (CAD) and ac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Clin Exp Med
Hlavní autoři: Ilter, Abdulselam, Orem, Cihan, Balaban Yucesan, Fulya, Sahin, Mursel, Hosoglu, Yusuf, Kurumahmutoglu, Elif, Ozer Yaman, Serap, Orem, Asim
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538003/
https://ncbi.nlm.nih.gov/pubmed/26309601
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky